Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

被引:0
作者
Alberto Lopez-Clavijo, Carlos [1 ,2 ,3 ,4 ]
Esteban Gaviria-Maya, Juan [5 ]
Eduardo Henao-Florez, Rodrigo [2 ]
Leandro Piedrahita-Gutierrez, Dany [3 ,6 ]
机构
[1] InSer Pereira, Pereira, Colombia
[2] Univ Caldas, Ginecol & Obstet, Manizales, Colombia
[3] Fdn Univ Autonoma Amer, Medellin, Colombia
[4] Univ Tecnol Pereira, Biol Mol & Biotecnol, Pereira, Colombia
[5] Univ Caldas, Manizales, Colombia
[6] InSer Pereira, Endocrinol Reprod Humana & Infertilidad, Pereira, Colombia
关键词
Amenorrhea; Galactorrhea; Hyperprolactinemia; Infertility; Magnetic Resonance Imaging; Prolactin; Prolactinoma;
D O I
10.17533/udea.iatreia.v29n3a04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included. Results: The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD +/- 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD +/- 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/mL. No significant association was found between serum prolactin level and the presence of prolactinoma. Conclusion: Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [41] Circulating Kisspeptin and Klotho Levels in Women with Hyperprolactinemia
    Arslan, Ismail Emre
    Ozturk, Beyza Olcay
    Bolayir, Basak
    Yalcin, Mehmet Muhittin
    Yetkin, Ilhan
    Akturk, Mujde
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 26 (03) : 115 - 119
  • [42] Body self-image disturbances in women with prolactinoma
    Pereira, Helen S.
    Naliato, Erika C.
    Moraes, Aline B.
    Gadelha, Monica R.
    Vieira Neto, Leonardo
    Almeida, Renan M.
    Nardi, Antonio E.
    Violante, Alice H.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (01) : 33 - 39
  • [43] The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS
    van der Ham, Kim
    Stekelenburg, Karlijn J.
    Louwers, Yvonne V.
    van Dorp, Wendy
    Schreurs, Marco W. J.
    van der Wal, Ronald
    Steegers-Theunissen, Regine P. M.
    Laven, Joop S. E.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [44] Bone density in women with prolactinoma treated with dopamine agonists
    Erika Cesar de Oliveira Naliato
    Alice Helena Dutra Violante
    Dayse Caldas
    Maria Lucia Fleiuss Farias
    Isabela Bussade
    Adilson Lamounier Filho
    Christiane Rezende Loureiro
    Rosita Fontes
    Yolanda Schrank
    Thaissa Loures
    Annamaria Colao
    Pituitary, 2008, 11 : 21 - 28
  • [45] Bone density in women with prolactinoma treated with dopamine agonists
    Naliato, Erika Cesar De Oliveira
    Violante, Alice Helena Dutra
    Caldas, Dayse
    Farias, Maria Lucia Fleiuss
    Bussade, Isabela
    Filho, Adilson Lamounier
    Loureiro, Christiane Rezende
    Fontes, Rosita
    Schrank, Yolanda
    Loures, Thaissa
    Colao, Annamaria
    PITUITARY, 2008, 11 (01) : 21 - 28
  • [46] Neuroleptic-Associated Hyperprolactinemia: Clinical Manifestations and Effects on Sexual Function
    Yunilainen O.A.
    Starostina E.G.
    Dzeranova L.K.
    Kudryashkina G.N.
    Kessel’man L.G.
    Baranov P.A.
    Dedov I.I.
    Neuroscience and Behavioral Physiology, 2018, 48 (3) : 358 - 366
  • [47] Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
    Deanna L Kelly
    Heidi J Wehring
    Amber K Earl
    Kelli M Sullivan
    Faith B Dickerson
    Stephanie Feldman
    Robert P McMahon
    Robert W Buchanan
    Dale Warfel
    William R Keller
    Bernard A Fischer
    Joo-Cheol Shim
    BMC Psychiatry, 13
  • [48] Clinical and Laboratory Characteristics of Hyperprolactinemia. The place of MRI in optimal management
    Jafarzade, Aytaj
    Mungan, Tamer M.
    AKTUALNI GYNEKOLOGIE A PORODNICTVI, 2023, 15 : 78 - 82
  • [49] Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
    Kelly, Deanna L.
    Wehring, Heidi J.
    Earl, Amber K.
    Sullivan, Kelli M.
    Dickerson, Faith B.
    Feldman, Stephanie
    McMahon, Robert P.
    Buchanan, Robert W.
    Warfel, Dale
    Keller, William R.
    Fischer, Bernard A.
    Shim, Joo-Cheol
    BMC PSYCHIATRY, 2013, 13
  • [50] Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics
    Milano, Walter
    D'Acunto, Cosimo Walter
    De Rosa, Michele
    Festa, Michela
    Milano, Luca
    Petrella, Claudio
    Capasso, Anna
    REVIEWS ON RECENT CLINICAL TRIALS, 2011, 6 (01) : 52 - 63